TMS Center of Colorado Introduces New Depression Treatment Technology to Colorado

Brainsway™ Deep TMS therapy doubles depression treatment success rate, cuts treatment times in half

TMS Center of Colorado Introduces New Depression Treatment Technology to Colorado

<0> Armada Medical MarketingDan Snyders, 303-623-1190 (x230) </0>

announces the new for patients suffering from treatment-resistant major depressive disorder (MDD). The center is the first and only facility in metro Denver to offer the Brainsway technology for the non-invasive treatment of MDD.

About 6.6 percent, or 380,000 Coloradoans, suffer from some form of depression, according to the , with about half of those suffering from MDD. For patients who have not responded to or cannot tolerate antidepressant medication, using Brainsway deep transcranial magnetic stimulation (TMS) offers a robust, electrically based treatment without any of the side effects of electric shock therapy.

TMS Center of Colorado Medical Director and CEO Ted Wirecki, M.D., said the technology’s effectiveness has been clinically proven in a prospective, double blind, randomized, controlled, multi-center trial, with long-term results maintained for at least 16 weeks.

“TMS is the future of treatment-resistant depression therapy, and we use the Brainsway system because it’s the strongest, most effective TMS system available,” said Wirecki. “Clinical trials that led to FDA clearance for the Brainsway system demonstrated excellent results in just half the average treatment time compared to existing TMS technology.”

Wirecki, a recognized psychiatrist with more than 20 years’ experience in the treatment of psychiatric disorders, said the new technology is now available to all patients and their referring physicians.

TMS therapy generates highly concentrated magnetic fields that turn on and off very rapidly. These magnetic fields are the same type and strength as those produced by a magnetic resonance imaging (MRI) machine. Deep TMS differs from standard TMS in that the magnetic pulse is able to reach much deeper areas of the brain. These deeper (limbic) areas of the brain impact mood regulation and motivation, which are commonly negatively affected in patients who are depressed.

Deep TMS treatment consists of 20 to 30 sessions over a four-week period. Each treatment session lasts approximately 20 to 30 minutes using the new Brainsway technology, compared to about 40 to 60 minutes per session for standard TMS treatments.

Medicare does not yet cover the cost of treatment; however, patients are encouraged to check with their individual insurance carrier for coverage. Although U.S. clinical trials are currently underway for treatment of a number of additional disorders, including bipolar disorder, post-traumatic stress disorder (PTSD) and chronic pain, Deep TMS is FDA cleared only for the treatment of depression.

For more information or an initial consultation, contact the TMS Center of Colorado at 303-884-3867.

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.